10X Genomics (TXG) PT Raised to $47 at Piper Sandler
Tweet
Share
E-mailGet Alerts TXG Hot Sheet
Price: $75.62 -6.29%
Rating Summary:
7 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Rating Summary:
7 Buy, 12 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
Piper Sandler analyst David Westenberg raised the price target on 10X Genomics (NASDAQ: TXG) to $47.00 (from $42.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Constellation Brands (STZ) PT Lowered to $145 at UBS on Softer Consumer Backdrop
- Pepsico (PEP) PT Lowered to $161 at BNP Paribas Exane, 'Expect Renewed Calls for Greater Urgency in NA'
- China Shenhua Energy (601088:CH) PT Raised to RMB53.60 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
